• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Womaness and Walmart Partner to Expand Access to Menopause Solutions

by Jasmine Pennic 04/22/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Womaness, a modern menopause brand offering a wide range of solutions, has announced a new partnership with Walmart. 

– Starting today, Womaness products will be available in select Walmart stores and online, as part of Walmart’s broader Women’s Intimate Health Space initiative. This collaboration aims to address the need for accessible, affordable, and effective menopause products.

Walmart Expands Access to Menopause Solutions

Walmart’s customer base aligns closely with Womaness’s target demographic, with 74% of Walmart shoppers being female and 68% falling within the Gen X and Boomer age ranges. This partnership seeks to fill a significant gap in the market by providing these customers with accessible and affordable perimenopause and menopause support, which has been historically lacking in the retailer’s offerings.

This expansion is in line with Womaness’s mission to break the taboo surrounding menopause, its diverse symptoms, and the broader topic of women’s aging. Womaness distinguishes itself in the women’s aging and wellness industry with its holistic approach to addressing the multifaceted needs of women navigating this stage of life. The brand offers a range of safe and stylish solutions in several categories, including skin and body care, feminine care, sexual health, and supplements. Womaness emphasizes product safety and efficacy, with all products being cruelty-free, vegan, dermatologist- and allergy-tested, and formulated without harmful ingredients like animal-derived substances, parabens, phthalates, sulfates, artificial colors, formaldehyde, mineral oils, estrogen, phytoestrogen, or added hormones.

Availability

As of today, Walmart customers can find nine Womaness products in over 1,000 select stores nationwide and on Walmart.com. The product selection includes: Active Glow, Let Me Sleep, Me.No.Pause, The Works, Daily V Soothe, Coco Bliss, Let’s Neck (online only), Fountain of Glow (online only), Eye Opener (online only), and Overnight Magic (online only). This partnership with Walmart is the second major retail expansion for Womaness, following its 2022 launch in ULTA, where it became the retailer’s first modern menopause brand.

“Women spend one third of their life in perimenopause and menopause,” said Womaness co-founder and CEO Sally Mueller. “That’s why our mission has and continues to be to change the conversation around this stage of life. To have a retail giant like Walmart join in on this mission means more women will have access to the products they need to not only address these often overlooked symptoms, but to also feel like their best self.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |